These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8444070)
1. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Davies GR; Wilkie ME; Rampton DS Dig Dis Sci; 1993 Mar; 38(3):417-25. PubMed ID: 8444070 [TBL] [Abstract][Full Text] [Related]
2. Effects of indomethacin and misoprostol on renal function in healthy volunteers. Wilkie ME; Davies GR; Marsh FP; Rampton DS Clin Nephrol; 1992 Dec; 38(6):334-7. PubMed ID: 1468165 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers. Davies NM; Jamali F Hum Exp Toxicol; 1997 Jul; 16(7):345-9. PubMed ID: 9257157 [TBL] [Abstract][Full Text] [Related]
4. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Bjarnason I; Smethurst P; Fenn CG; Lee CE; Menzies IS; Levi AJ Dig Dis Sci; 1989 Mar; 34(3):407-11. PubMed ID: 2493366 [TBL] [Abstract][Full Text] [Related]
5. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Hond ED; Peeters M; Hiele M; Bulteel V; Ghoos Y; Rutgeerts P Aliment Pharmacol Ther; 1999 May; 13(5):679-85. PubMed ID: 10233193 [TBL] [Abstract][Full Text] [Related]
6. Small bowel permeability--a variable effect of NSAIDS. Choi VM; Coates JE; Chooi J; Thomson AB; Russell AS Clin Invest Med; 1995 Oct; 18(5):357-61. PubMed ID: 8529318 [TBL] [Abstract][Full Text] [Related]
7. Absorption, retention and urinary excretion of chromium-51 in rats pretreated with indomethacin and dosed with dimethylprostaglandin E2, misoprostol or prostacyclin. Kamath SM; Stoecker BJ; Davis-Whitenack ML; Smith MM; Adeleye BO; Sangiah S J Nutr; 1997 Mar; 127(3):478-82. PubMed ID: 9082033 [TBL] [Abstract][Full Text] [Related]
8. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563 [TBL] [Abstract][Full Text] [Related]
9. Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers. Rainsford KD; James C; Hunt RH; Stetsko PI; Rischke JA; Karim A; Nicholson PA; Smith M; Hantsbarger G Clin Pharmacol Ther; 1992 Apr; 51(4):415-21. PubMed ID: 1563211 [TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Sigthorsson G; Crane R; Simon T; Hoover M; Quan H; Bolognese J; Bjarnason I Gut; 2000 Oct; 47(4):527-32. PubMed ID: 10986213 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Leite AZ; Sipahi AM; DamiĆ£o AO; Coelho AM; Garcez AT; Machado MC; Buchpiguel CA; Lopasso FP; Lordello ML; Agostinho CL; Laudanna AA Gut; 2001 Feb; 48(2):163-7. PubMed ID: 11156635 [TBL] [Abstract][Full Text] [Related]
12. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566 [TBL] [Abstract][Full Text] [Related]
13. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. Banerjee AK; Peters TJ Gut; 1990 Dec; 31(12):1358-64. PubMed ID: 1979954 [TBL] [Abstract][Full Text] [Related]
14. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man. Oman H; Blomquist L; Henriksson AE; Johansson SG Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970 [TBL] [Abstract][Full Text] [Related]
15. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine. Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652 [TBL] [Abstract][Full Text] [Related]
16. In vivo influence of nicotine on human basal and NSAID-induced gut barrier function. Suenaert P; Bulteel V; Den Hond E; Geypens B; Monsuur F; Luypaerts A; Ghoos Y; Rutgeerts P Scand J Gastroenterol; 2003 Apr; 38(4):399-408. PubMed ID: 12739712 [TBL] [Abstract][Full Text] [Related]
17. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model. Davies NM; Wright MR; Jamali F Pharm Res; 1994 Nov; 11(11):1652-6. PubMed ID: 7870685 [TBL] [Abstract][Full Text] [Related]
18. The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugs. Davies GR; Rampton DS Aliment Pharmacol Ther; 1991 Dec; 5(6):593-8. PubMed ID: 1782303 [TBL] [Abstract][Full Text] [Related]
19. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios. Oman H; Henriksson AE; Johansson SG; Blomquist L Scand J Gastroenterol; 1996 Dec; 31(12):1182-8. PubMed ID: 8976010 [TBL] [Abstract][Full Text] [Related]
20. Experimental evidence of the benefit of misoprostol beyond the stomach in humans. Bjarnason I J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]